CVM was one of my initial investments in pre-revenue biotech stocks. My advice is to stay as far away from it as as you can. I was in it for years, and I have used it on this board many times (without naming it) as to why reverse splits can be a disaster. The CEO, Geert, who I used to see in the mornings walking his dog, did so many reverse splits that I lost count. He did them every time the sp fell below $2 and the NYSE threatened to delist them. I know CVM and their history behind it, including family ties, better than CYDY and that's saying something. What amazes me is that after the long trial for neck cancer failed, the longs still believe there's something of value in it and expect it to rise like a phoenix from the flames. I can't believe they're still pumping it.

Quote:

---

The company is CEL-SCI... the Cancer product Multikine is used for 3 weeks prior to surgery...apparently reduces size etc. and then SOC....trades at ten times our current value...they have had talks with Merck.

---